Marinus Pharmaceuticals, Inc Email Format

PharmaceuticalsUnited States11-50 Employees

Marinus Pharmaceuticals, Inc. is a United States–based specialty pharmaceutical company focused on reformulating, developing, and commercializing novel drugs to treat serious neurological, psychiatric, and pain disorders. Its lead therapy is described as first-in-class for epilepsy, reflecting the company’s emphasis on neurological conditions and innovative treatment approaches. The firm serves patients and healthcare providers seeking new options for difficult-to-treat conditions, with a portfolio built around ganaxolone and related formulations studied for disorders such as CDKL5 deficiency disorder and other epileptic conditions. Based in Branford, Connecticut, Marinus operates within the pharmaceutical manufacturing sector and collaborates with partner organizations to extend the reach and potential impact of its therapies. In recent developments, the company has been involved in a merger transaction with Immedica, reflecting strategic consolidation aimed at expanding its footprint and capabilities.

Get verified Marinus Pharmaceuticals, Inc emails free

Company overview Employee directory